Gary R. Shapiro

868 total citations
23 papers, 666 citations indexed

About

Gary R. Shapiro is a scholar working on Oncology, Molecular Biology and General Health Professions. According to data from OpenAlex, Gary R. Shapiro has authored 23 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 4 papers in General Health Professions. Recurrent topics in Gary R. Shapiro's work include Cancer Treatment and Pharmacology (5 papers), Global Cancer Incidence and Screening (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Gary R. Shapiro is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Global Cancer Incidence and Screening (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Gary R. Shapiro collaborates with scholars based in United States, Italy and Iceland. Gary R. Shapiro's co-authors include Mark Siegler, R. M. Walker, Carol Stocking, Gregory P. Gramelspacher, John D. Lantos, Peter Singer, Miguel Ángel Sánchez-González, Lawrence Johnson, Craig Evan Pollack and Lee Bone and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The American Journal of Medicine.

In The Last Decade

Gary R. Shapiro

23 papers receiving 629 citations

Peers

Countries citing papers authored by Gary R. Shapiro

Since Specialization

Citations

This map shows the geographic impact of Gary R. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Shapiro more than expected).

Fields of papers citing papers by Gary R. Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Shapiro. The network helps show where Gary R. Shapiro may publish in the future.

Co-authorship network of co-authors of Gary R. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Shapiro. A scholar is included among the top collaborators of Gary R. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Shapiro. Gary R. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer 2018 ·Journal of Thoracic Oncology ·Alexander Drilon, Jennifer Clark, Jonathan M. Weiss, (unknown), (unknown), Benjamin Solomon, (unknown), Liza C. Villaruz, G. Riely, (unknown), Gary R. Shapiro, Danielle Murphy, (unknown), Tiziana Usari, (unknown), K. Wilner, Paul K. Paik	6
2	Predicting neutropenia risk in patients with cancer using electronic data 2016 ·Journal of the American Medical Informatics Association ·Pamala A. Pawloski, Avis J. Thomas, (unknown), Gabriela Vazquez‐Benitez, Gary R. Shapiro, Gary H. Lyman	15
3	Effect of Patient Navigation on Breast Cancer Screening Among African American Medicare Beneficiaries: A Randomized Controlled Trial 2015 ·Journal of General Internal Medicine ·(unknown), (unknown), Jean G. Ford, (unknown), Saifuddin Ahmed, Lee Bone, Jennifer Wenzel, Gary R. Shapiro, Mollie Howerton, Lawrence Johnson, Qiana L. Brown, (unknown), Craig Evan Pollack	60
4	Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults 2014 ·Cancer Causes & Control ·Hisani N. Horne, (unknown), Craig Evan Pollack, Diane Markakis, Jennifer Wenzel, Saifuddin Ahmed, Mary A. Garza, Gary R. Shapiro, Lee Bone, Lawrence Johnson, Jean G. Ford	61
5	Multiple Myeloma in the Very Old: An IASIA Conference Report 2014 ·JNCI Journal of the National Cancer Institute ·Sascha A. Tuchman, Gary R. Shapiro, William B. Ershler, Ashraf Badros, Harvey Jay Cohen, Angela Dispenzieri, (unknown), Bindu Kanapuru, Donald A. Jurivich, Dan L. Longo, (unknown), Antonio Palumbo, Jeremy Walston, Jerome W. Yates	13
6	The Relationship Between Education and Prostate-Specific Antigen Testing Among Urban African American Medicare Beneficiaries 2014 ·Journal of Racial and Ethnic Health Disparities ·Mohammad K. Hararah, Craig Evan Pollack, Mary A. Garza, Hsin‐Chieh Yeh, Diane Markakis, (unknown), Jennifer Wenzel, Gary R. Shapiro, Lee Bone, Lawrence Johnson, Jean G. Ford	13
7	Gender Differences in Correlates of Colorectal Cancer Screening Among Black Medicare Beneficiaries in Baltimore 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Kathryn A. Martinez, Craig Evan Pollack, (unknown), Diane Markakis, Lee Bone, Gary R. Shapiro, Jennifer Wenzel, Mollie Howerton, Lawrence Johnson, Mary A. Garza, Jean G. Ford	14
8	Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493) 2012 ·Leukemia & lymphoma ·Peter H. Wiernik, Hailun Li, Edie Weller, Howard S. Höchster, Sandra J. Horning, Tipu Nazeer, Leo I. Gordon, Thomas M. Habermann, (unknown), Gary R. Shapiro, Peter A. Cassileth	4
9	An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC). 2011 ·Journal of Clinical Oncology ·Kwok‐Kin Wong, (unknown), (unknown), Eugene Paschold, Leora Horn, Joelle Lufkin, Ronald K. Blackman, Florentina Teofilovici, Gary R. Shapiro, Mark A. Socinski	47
10	Phase I/II Study of Vinorelbine and Exisulind as First-Line Treatment of Advanced Non-small Cell Lung Cancer in Patients at Least 70 Years Old: A Wisconsin Oncology Network Study 2008 ·Journal of Thoracic Oncology ·Steven Attia, Anne M. Traynor, KyungMann Kim, (unknown), Tien Hoang, Harish G. Ahuja, Peter A. Beatty, Richard M. Hansen, Gregory A. Masters, Kurt R. Oettel, Gary R. Shapiro, Martha Larson, Marilyn Larson, Joan H. Schiller	2
11	A randomized trial of a representational intervention to decrease cancer pain (RIDCancerPain). 2008 ·Health Psychology ·Sandra E. Ward, Heidi Donovan, Sigríður Gunnarsdóttir, Ronald C. Serlin, Gary R. Shapiro, Susan Hughes	66
12	Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer 2007 ·Cancer Chemotherapy and Pharmacology ·Howard H. Bailey, Steven Attia, Richard R. Love, (unknown), Rick Chappell, Kendra D. Tutsch, (unknown), (unknown), Richard M. Hansen, Gary R. Shapiro, James A. Stewart	52
13	GTX chemotherapy for metastatic pancreatic cancer: Response, survival, and toxicity data 2004 ·Journal of Clinical Oncology ·Robert L. Fine, David R. Fogelman, Stephen M. Schreibman, Susan C. Guba, J.B. Sharma, Gary R. Shapiro	11
14	GTX chemotherapy for metastatic pancreatic cancer: Response, survival, and toxicity data 2004 ·Journal of Clinical Oncology ·Robert L. Fine, David R. Fogelman, Stephen M. Schreibman, Susan C. Guba, J.B. Sharma, Gary R. Shapiro	2
15	Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer 2003 ·Lung Cancer ·Tien Hoang, KyungMann Kim, Anthony J. Jaslowski, Paul Koch, Peter A. Beatty, (unknown), (unknown), Gary R. Shapiro, Robert S. Witte, Joan H. Schiller	54
16	Are there Limits to Oncology Care? (Futility) 2000 ·Cancer treatment and research ·Gary R. Shapiro	2
17	Who Lives Here? Survey Undercoverage and Household Roster Questions 1997 ·Roger Tourangeau, Gary R. Shapiro, (unknown), (unknown)	28
18	The illusion of futility in clinical practice 1989 ·The American Journal of Medicine ·John D. Lantos, Peter Singer, R. M. Walker, Gregory P. Gramelspacher, Gary R. Shapiro, Miguel Ángel Sánchez-González, Carol Stocking, (unknown), Mark Siegler	176
19	The illusion of futility in clinical practice☆ 1989 ·The American Journal of Medicine ·John D. Lantos, Peter Singer, R. M. Walker, Gregory P. Gramelspacher, Gary R. Shapiro, Miguel Ángel Sánchez-González, Carol Stocking, (unknown), Mark Siegler	10
20	Long‐term follow‐up of prosthetic joint replacement in hemophilia 1986 ·American Journal of Hematology ·(unknown), Gary R. Shapiro, David Green	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact